VIRAL HEPATITIS
Clinical trials for VIRAL HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new VIRAL HEPATITIS trials appear
Sign up with your email to follow new studies for VIRAL HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo challenges standard treatment for hepatitis d
Disease control OngoingThis study is testing whether a new two-drug combination (Tobevibart+Elebsiran) works better than the current standard treatment (bulevirtide) for people with chronic hepatitis D virus (HDV) infection. About 100 adults with stable liver disease will receive either the new combina…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug duo aims to knock out hepatitis d virus
Disease control OngoingThis Phase 3 trial is testing whether a combination of two drugs, tobevibart and elebsiran, can effectively treat chronic hepatitis D infection. It will compare people who receive the treatment right away to those whose treatment is delayed. The main goal is to see if the treatme…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC